10x Insights
Loading account…
Companies / Healthcare / TRANSCAT INC
TRNS

TRANSCAT INC

HealthcareMedical Instruments
Ticker TRNSROCHESTER, NYFiscal year ends MarchBook value per share $31.97Diluted shares 9.5M

Transcat, Inc. (Nasdaq: TRNS) is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system, and pipette services to highly regulated industries. The company operates through two complementary business segments:… From the company’s description.

Fiscal year 2026 · ends 03-27Changes are against fiscal 2025The amber dot is the latest twelve months, to 2026-06-27
Sales & profitability
$331.88M
+19.2% year over year
Last 12 mo $348.40M
4.00%
−2.4 percentage points
Last 12 mo 3.34%
$5.38M
−63.0% year over year
Last 12 mo $3.45M
1.79%
−3.3 percentage points
Last 12 mo 1.14%
Cash & financing
$34.85M
−10.6% year over year
Last 12 mo $40.04M
$19.55M
−24.2% year over year
Last 12 mo $25.36M
0.33
Was 0.11× a year earlier
Last 12 mo 0.36
9.4M
+1.4% year over year
Last 12 mo 9.5M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What TRANSCAT INC does

In the company’s own words

Transcat, Inc. (Nasdaq: TRNS) is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system, and pipette services to highly regulated industries. The company operates through two complementary business segments: Service and Distribution. The Service segment generates the majority of revenue and offers calibration, repair, inspection, analytical qualifications, preventative maintenance, and consulting services primarily to life sciences, pharmaceutical, biotechnology, medical device, aerospace, defense, energy, and utilities customers. The Distribution segment markets, sells, and rents more than 75,000 test, measurement, and control instruments from approximately 400 leading brands globally.

As of March 28, 2026, Transcat employed 1,413 people and operated 33 calibration service centers strategically located across the United States, including Puerto Rico, Canada, and Ireland, with an additional center in Costa Rica acquired in April 2026. The company serves approximately 27,000 customers, with twenty to twenty-five percent transacting through both business segments. All calibration service centers maintain ISO/IEC 17025:2017 accreditation, which the company considers a cornerstone of its quality program and competitive differentiator.

The company's proprietary asset management systems, CalTrak® and C3®, provide customers with integrated documentation, workflow management, and web-based compliance tracking validated to FDA requirements. Transcat performs over 1.2 million calibrations annually and offers flexible service delivery options including in-house services, periodic onsite services, client-based laboratory services, and mobile calibration units. The Distribution segment operates from a 48,500 square-foot facility in Rochester, New York, along with smaller warehouses in Vista, California and Houston, Texas, shipping approximately 36,000 product orders annually.

Transcat's growth strategy emphasizes organic expansion and strategic acquisitions targeting geographic expansion, increased capabilities, and infrastructure leverage. Recent acquisitions include Essco Calibration Laboratory in Boston, Martin Calibration in Minneapolis, Becnel Rental Tools in Louisiana, and SCM Metrology in Costa Rica. The company maintains registered trademarks including Transcat®, CalTrak®, C3®, and Calibrated by Transcat®. Visit www.transcat.com for additional information.

Company details
Sector
Healthcare
Industry
Medical Instruments
Headquarters
ROCHESTER, NY
Fiscal year end
March
CIK
99302
SIC
3825

Financial performance, year by year

Fiscal 2014–2026 · USD
$-34.84M$69.68M$174.20M$278.72M$383.24M2014201520162017201820192020202120222023202420252026Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns TRANSCAT INC — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

198
funds hold it
0 of 35
superinvestors hold it
$392.19M
held by funds, at market
47.2%
of shares held by funds

Largest fund holders · TRANSCAT INC’s weight in each

Neuberger Genesis Fund
NBGNX · NEUBERGER BERMAN EQUITY FUNDS
0.51%of fund net assets
Hood River Small-Cap Growth Fund
HRSMX · Manager Directed Portfolios
0.56%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
CONESTOGA SMALL CAP FUND
CCASX · Conestoga Funds
1.18%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.03%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do TRANSCAT INC and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of TRANSCAT INC's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in TRANSCAT INC's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.